Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEPAVALV: Balloon Aortic Valvuloplasty Without Heparin
NCT01823393Phase 4Terminated
- Sponsor
- CHU Montpellier
- Start
- Jan 2013
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in aortic stenosis (AS), sponsored by CHU Montpellier. Started Jan 2013; status: terminated.
02
Drugs
heparin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT01823393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01823393.